Alerts will be sent to your verified email
Verify Email
GLAND
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Gland Pharma Limited focuses on providing affordable and high-quality injectables across various therapeutic areas and delivery systems including complex injectables and new delivery systems like pens and cartridges.
Gland Pharma major competitors are Caplin Point Lab, Gufic Biosciences, Ajanta Pharma, JB Chem & Pharma, Ipca Laboratories, Eris Lifesciences, Pfizer.
Market Cap of Gland Pharma is ₹30,760 Crs.
While the median market cap of its peers are ₹24,226 Crs.
Gland Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Gland Pharma is 11.54 and is ranked 5 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | ||||||||||||
| Investor Presentation | May Aug | Feb Mar Jun Sep Dec | Mar Jun Sep Dec | Mar May Jun Jul Sep Dec | Jan Mar Jun Sep Dec | Dec | ||||||||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | ||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
